Navigation Links
China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results
Date:11/23/2007

pipeline, shareholders will be rewarded. There is still a great opportunity for pharmaceutical firms like ours to prosper in China and provide investors with access to this rapidly growing and evolving industry.''

Nine Month Financial Results

Revenue for the nine months ended September 30, 2007 increased 34% to $22.5 million compared to $16.8 million for the period ended September 30, 2006. The increase in revenues again was attributable to the revenue growth of the Company's subsidiary Eyre. Additionally, the Company had to restate revenues and earnings from its Enshi subsidiary as it was determined that the previous owner had booked false accounts.

Gross profit increased 44% for the nine months ended September 30, 2007 to $6 million compared to $4.18 million for the same period in 2006. The gross profit margin for the nine months ended September 30, 2007 was 26.5% compared to 25% for the same period in 2006.

Income from operations for the nine months ended September 30, 2007 was approximately the same at $1.42 million compared to $1.44 million for the same period in 2006. The slight decrease in operating profit was related to an increase in operating expenses from $4.55 million for the nine months ended September 30, 2007 versus $2.73 million a year ago. The increase in these expenses was mainly realized in the third quarter for the reasons detailed above.

The Company reported a net loss for the nine month period of 2007 of $917 thousand compared to a net income of $117 thousand for the nine months of 2006, before one-time losses on discontinued operations. The net loss for the quarter was mainly attributable to the higher payment and accrued interest expenses as a result of the acquisition financing loan due to RimAsia Capital Partners for Enshi.

As discussed above, the Company took a one-time charge of $10.8 million related to the write-off of the Enshi subsidiary which it no longer owns. Additionally, the Company had a
'/>"/>

SOURCE China Biopharmaceuticals Holdings, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... JUNCTION, N.J. , Aug. 27, 2014 ... innovative drug delivery technologies, today announced that it has ... Jersey Business & Industry Association,s 2014 Awards for ... were selected by an independent panel of judges from ... company volunteers. Award winners will be honored at a ...
(Date:8/27/2014)... White City, OR (PRWEB) August 27, 2014 ... Supply Report, “Consolidation continues to reshape the look and ... in nutrition. Consumer demand for higher-quality ingredients will push ... the North American market have experienced strong market growth ... and ethical attributes in their food and cosmetics to ...
(Date:8/26/2014)... believe is the thinnest-possible semiconductor, a new class ... atoms thick. , The University of Washington researchers ... materials can be connected in an atomically seamless ... be the basis for next-generation flexible and transparent ... technologies. , "Heterojunctions are fundamental elements of electronic ...
(Date:8/26/2014)... The 20 ambassadors representing the ALS ... issued the following statement on Facebook today regarding the ... new funding specifically for ALS research: , “Who would ... ice would raise all this awareness and funding toward ... on behalf of the entire ALS community, would like ...
Breaking Biology Technology:Tris Pharma Selected as an award winner in the New Jersey Business & Industry Association's 2014 Awards for Excellence 2Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 2Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 3Scientists craft atomically seamless, thinnest-possible semiconductor junctions 2ALS TDI’s Young Faces of ALS Ambassadors Thank You for Accepting the Ice Bucket Challenge to End ALS 2ALS TDI’s Young Faces of ALS Ambassadors Thank You for Accepting the Ice Bucket Challenge to End ALS 3ALS TDI’s Young Faces of ALS Ambassadors Thank You for Accepting the Ice Bucket Challenge to End ALS 4
... the Wisconsin Technology Council have released a report detailing ... the difficulties that still need to be addressed to ... ,Wisconsin Technology Council President Tom Still pointed out ... have lost 10 to 15 percent of their technology ...
... study reported in the June 2005 issue of ... predominant. But many companies, even in people businesses, ... need to excel. While organizations have perfected sophisticated ... production and flow of goods and services, their ...
... optimistic that his bill requiring notification of electronic ... year. , ,Senate Bill 164, co-authored by ... require companies that keep personal data on customers ... data is obtained by unauthorized parties. Kanavas said ...
Cached Biology Technology:Report: Wisconsin still lags in college degrees held by workforce, leads elsewhere 2Report: Wisconsin still lags in college degrees held by workforce, leads elsewhere 3Four steps to making talent management a core competence 2Four steps to making talent management a core competence 3Four steps to making talent management a core competence 4Kanavas thinks personal ID theft bill will pass this year 2
(Date:8/27/2014)... of Warwick research finds , Gamblers show the ... new research has shown. , Researchers, led by Dr ... Psychology, conducted tests that found that both human gamblers ... high-value than low-value rewards. , Published in Biology ... show the important role that memories of previous biggest ...
(Date:8/26/2014)... developed algorithms to identify weak spots in tendons, muscles ... which needs to be refined before it is used ... and tiny injuries in the body,s tissues long before ... Aug. 27 in the Journal of the Royal ... of the physical and life sciences. , "Tendons are ...
(Date:8/26/2014)... of Warwick have provided the first evidence that ... linked to early signs of dementia. , Published ... that the absence of the protein MK2/3 promotes ... nervous system. These changes were shown to have ... including restricted learning and memory formation capabilities. , ...
Breaking Biology News(10 mins):Gamblers are greedy bird-brains, University of Warwick research finds 2New technology may identify tiny strains in body tissues before injuries occur 2New technology may identify tiny strains in body tissues before injuries occur 3Lack of naturally occuring protein linked to dementia 2
... Europe,s first personalized treatment for lung cancer heralds the ... that will demand significant changes to the way cancer ... said today at the 2nd European Lung Cancer Conference ... Medical University of Vienna said that personalized therapy, in ...
... first trial of an important new combination therapy of ... in lung cancer has delivered promising results, French researchers ... The results of the Phase I trial suggest ... well-enough tolerated to allow it to be administered at ...
... allows precise targeting of radiotherapy using real-time X-ray images has ... administered to lung and liver cancers while minimizing harm to ... Cancer Conference. "With this study we show that it ... that can give information at any time before or during ...
Cached Biology News:Making personalized lung cancer therapy a reality in Europe 2First trial of pemetrexed with radiation and chemo in lung cancer shows promising results 2
Human monocyte-derived dendritic cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Dendritic Cells and EPCs...
...
...
...
Biology Products: